Skip to content
Screener

Axogen AXGN Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Baxter International logo
Baxter InternationalBAX
$67M+1.5%
IAR
Integra LifeSciencesIART
$7.33M+6.9%
Bioventus logo
BioventusBVS
$2.61M-9.9%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$1.51M+30.8%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$2.23M+24.5%
MiMedx Group logo
MiMedx GroupMDXG
$14.8M+275%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.59B+302%
Enterprise value$2.52B+266%
P/S10.3×+7.1×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Axogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094
Line itemJune 30, 2026December 31, 2025
Cash and cash equivalents$94,572$35,548
Restricted cash2,0004,000
Investments16,8405,980
Accounts receivable, net of allowance for doubtful accounts of $734 and $948, respectively34,12626,169
Inventory47,31342,373
Prepaid expenses and other assets5,5256,352
Total current assets200,376120,422
Property and equipment, net82,34281,783

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's allowance for doubtful accounts receivable (current)?
Axogen (AXGN) reported allowance for doubtful accounts receivable (current) of $734K in Q2 2026.
How has Axogen's allowance for doubtful accounts receivable (current) changed year-over-year?
Axogen's allowance for doubtful accounts receivable (current) decreased by 35.8% year-over-year, from $1.14M to $734K.
What is the long-term trend for Axogen's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Axogen's allowance for doubtful accounts receivable (current) has grown at a 17.9% compound annual growth rate (CAGR), from $416K to $948K.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Axogen's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude